Quantcast
Home > Quotes > XOMA
XOMA

XOMA Corporation Common Stock (XOMA) Quote & Summary Data

$13.42
*  
0.15
1.13%
Get XOMA Alerts
*Delayed - data as of Nov. 14, 2018  -  Find a broker to begin trading XOMA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 11.26 / $ 13.41
Today's High / Low
$ 13.90 / $ 13.01
Share Volume
234,386
50 Day Avg. Daily Volume
95,341
Previous Close
$ 13.27
52 Week High / Low
$ 37.25 / $ 11.88
Market Cap
112,561,538
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
234,386
50 Day Avg. Daily Volume:
95,341

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.40

Trading Range

The current last sale of $13.42 is 12.96% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 13.90 $ 37.25
 Low: $ 13.01 $ 11.88

Company Description (as filed with the SEC)

XOMA Corporation ("XOMA"), a Delaware corporation, has a long history of discovering and developing innovative therapeutics derived from its unique platform of antibody technologies. Over our 37 year history, we built an extensive portfolio of fully-funded programs by advancing product candidates into the earlier stages of development and then licensing them to licensees who assumed the responsibilities of later stage development, approval and commercialization. Fully-funded programs are those for which our partners pay all of the development and commercialization costs. As licensees advance these programs, we are eligible for potential milestone and royalty payments. In March 2017, we transformed our business model to become a royalty aggregator where we focus on expanding our portfolio of fully-funded programs by out-licensing our internally developed product candidates and acquiring potential milestone and royalty revenue streams on additional product candidates.  ... More ...  


Risk Grade

Where does XOMA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 13.44
Open Date:
Nov. 14, 2018
Close Price:
$ 13.27
Close Date:
Nov. 13, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x